Your session is about to expire
← Back to Search
Telemetric Intervention for Liver Transplant Patients (iMALT Trial)
iMALT Trial Summary
This trial is testing a new way to help people who have had a liver transplant take their medicine properly, in the hopes of reducing the number of transplants that are rejected.
iMALT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowiMALT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iMALT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had an organ transplant, but it was not the liver.I am between 12 and 19 years old.It has been over 2.5 years since my last liver transplant.I am currently taking tacrolimus.
- Group 1: Telemetric Intervention Arm
- Group 2: Standard of Care Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies available in this research program for individuals seeking treatment?
"The trial, which first appeared on November 14th 2018 and was last updated on August 2nd 2022 is actively searching for potential candidates as highlighted by clinicaltrials.gov."
Are there a number of healthcare facilities conducting this research trial in the city?
"This trial is welcoming patients from the Children's Hospital of Pittsburgh in Pennsylvania, Texas Children's Hospital in Houston and Columbia University Medical Center in New york as well as 13 other medical centres."
What conditions must potential participants meet to qualify for the experimental protocol?
"For this study, 156 participants aged 12-19 who have undergone transplant surgery are being sought. To be eligible for the trial, these individuals must meet further criteria such as a minimum of 2.5 years since their last liver transplantation and obtain parental consent and adolescent assent at enrollment."
Is this trial available to individuals who have surpassed the age of majority?
"As indicated by the requirements listed on this trial, only individuals between ages 12 and 19 are eligible to participate."
To what extent has this investigation been populated by participants?
"This study necessitates 156 participants that fulfill the predetermined requirements. These individuals can receive treatment at Children's Hospital of Pittsburgh in Pennsylvania and Texas Children's Hospital in Houston, among other possible locations."
Share this study with friends
Copy Link
Messenger